- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tibet Rhodiola Pharmaceutical Holding Co (600211)
Tibet Rhodiola Pharmaceutical Holding Co stock price live, this page displays SS 600211 stock exchange data. View the 600211 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Tibet Rhodiola Pharmaceutical Holding Co real time stock price chart below.
What Is the Tibet Rhodiola Pharmaceutical Holding Co Stock Price Today?
The Tibet Rhodiola Pharmaceutical Holding Co stock price today is 41.89.
What Is the Stock Symbol for Tibet Rhodiola Pharmaceutical Holding Co?
The stock symbol for Tibet Rhodiola Pharmaceutical Holding Co is "600211."
What Stock Exchange Does Tibet Rhodiola Pharmaceutical Holding Co Trade On?
Tibet Rhodiola Pharmaceutical Holding Co is listed and trades on the Shanghai stock exchange.
Is Tibet Rhodiola Pharmaceutical Holding Co a Good Stock to Buy?
Determining whether Tibet Rhodiola Pharmaceutical Holding Co—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600211 quote. (ISIN: CNE000000ZW7)
What Is the Tibet Rhodiola Pharmaceutical Holding Co Stock Price Today?
The Tibet Rhodiola Pharmaceutical Holding Co stock price today is 41.89.
What Is the Stock Symbol for Tibet Rhodiola Pharmaceutical Holding Co?
The stock symbol for Tibet Rhodiola Pharmaceutical Holding Co is "600211."
What Stock Exchange Does Tibet Rhodiola Pharmaceutical Holding Co Trade On?
Tibet Rhodiola Pharmaceutical Holding Co is listed and trades on the Shanghai stock exchange.
Is Tibet Rhodiola Pharmaceutical Holding Co a Good Stock to Buy?
Determining whether Tibet Rhodiola Pharmaceutical Holding Co—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600211 quote. (ISIN: CNE000000ZW7)
Shanghai
Currency in CNY
41.89
-0.36(-0.85%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
41.64
42.29
52 wk Range
34.93
57.98
Earnings results expected in 5 days
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
41.6442.29
52 wk Range
34.9357.98
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.43%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.43%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
600211 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 3 consecutive years
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Tibet Rhodiola Pharmaceutical Holding Co. produces and sells pharmaceutical products in China and internationally. The company offers modern Tibetan Medicines, including Nodikang capsules and granules, snow mountain golden arhat pain relief film, and ten-flavor Tida capsules; modern Chinese medicines, such as children Shuangqing granules, lipid clearing capsules, ginseng and zhi capsules, puyu capsules, and epilepsy flat film; and recombinant human brain natriuretic peptide for injection. It also provides isosorbide mononitrate sustained-release tablets; and oxygen rhodiola rosea moisturizing essence, secret recipe fragrance powder packet, rhodiola rosea, and Yuan Yang rhodiola rosea moisturizing essence products. In addition, the company offers biopharmaceuticals, traditional Chinese medicine, and chemical drugs for various fields, such as cardiovascular and cerebrovascular diseases, hepatobiliary diseases, orthopedic pain relief, rheumatism, and cold medicines. The company was founded in 1999 and is headquartered in Lhasa, China.
Compare 600211 to Peers and Sector
Metrics to compare | 600211 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600211PeersSector | |
|---|---|---|---|---|
P/E Ratio | 14.4x | 19.2x | −0.5x | |
PEG Ratio | −1.34 | −0.70 | 0.00 | |
Price/Book | 3.6x | 1.4x | 2.6x | |
Price / LTM Sales | 4.5x | 1.3x | 3.3x | |
Upside (Analyst Target) | - | 18.4% | 43.8% | |
Fair Value Upside | Unlock | 25.5% | 5.3% | Unlock |
Earnings
Latest Release
Mar 12, 2026
EPS / Forecast
0.67 / --
Revenue / Forecast
892.27M / --
FAQ
What Is the Tibet Rhodiola Pharm (600211) Stock Price Today?
The Tibet Rhodiola Pharm stock price today is 41.89 CNY.
What Stock Exchange Does Tibet Rhodiola Pharm Trade On?
Tibet Rhodiola Pharm is listed and trades on the Shanghai Stock Exchange.
What Is the Stock Symbol for Tibet Rhodiola Pharm?
The stock symbol for Tibet Rhodiola Pharm is "600211."
Does Tibet Rhodiola Pharm Pay Dividends? What’s The Current Dividend Yield?
The Tibet Rhodiola Pharm dividend yield is 4.43%.
What Is the Tibet Rhodiola Pharm Market Cap?
As of today, Tibet Rhodiola Pharm market cap is 13.50B CNY.
What Is Tibet Rhodiola Pharm's Earnings Per Share (TTM)?
The Tibet Rhodiola Pharm EPS (TTM) is 2.91.
When Is the Next Tibet Rhodiola Pharm Earnings Date?
Tibet Rhodiola Pharm will release its next earnings report on Apr 24, 2026.
From a Technical Analysis Perspective, Is 600211 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Tibet Rhodiola Pharm Stock Split?
Tibet Rhodiola Pharm has split 4 times.
How Many Employees Does Tibet Rhodiola Pharm Have?
Tibet Rhodiola Pharm has 671 employees.
What is the current trading status of Tibet Rhodiola Pharm (600211)?
As of Apr 19, 2026, Tibet Rhodiola Pharm (600211) is trading at a price of 41.89 CNY, with a previous close of 42.25 CNY. The stock has fluctuated within a day range of 41.64 CNY to 42.29 CNY, while its 52-week range spans from 34.93 CNY to 57.98 CNY.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.